Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Arimoclomol citrate (BRX-220 citrate) is a heat shock protein (HSP) co-inducer that acts by enhancing Hsp expression and directly impacting protein aggregation, clearance of misfolded assemblies, and the proteasome-ubiquitin system. This compound is known for its ability to protect motor neurons.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | $ 1,520.00 |
Description | Arimoclomol citrate (BRX-220 citrate) is a heat shock protein (HSP) co-inducer that acts by enhancing Hsp expression and directly impacting protein aggregation, clearance of misfolded assemblies, and the proteasome-ubiquitin system. This compound is known for its ability to protect motor neurons. |
In vivo | Arimoclomol (BRX-220; 20 mg/kg; orally administered for 5 days) demonstrated a protective effect against cholecystokinin-octapeptide (CCK)-induced acute pancreatitis in male Wistar rats weighing 240 to 270 g. The compound was administered intragastrically at a dosage of 20 mg/kg for a duration of 5 days, resulting in a protective outcome against acute pancreatitis induced by CCK. |
Synonyms | Arimoclomol citrate, BRX-220 citrate |
Molecular Weight | 505.91 |
Formula | C20H28ClN3O10 |
CAS No. | 368860-21-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Arimoclomol citrate 368860-21-3 BRX 220 Citrate BRX220 Citrate Arimoclomol Citrate BRX-220 Citrate BRX-220 citrate inhibitor inhibit